This site is intended for Healthcare Professionals only.

RPS delivers its commitment to divest from fossil fuels

Date:

Share post:

The Royal Pharmaceutical Society (RPS) has announced that it has delivered its commitment to divest from fossil fuels.

Divestment in fossil fuels is when an organisation sells any direct financial investments, such as stocks, bonds, or investment funds it has in companies that extract fossil fuels, such as coal, gas, oil and tar sands.

RPS President Professor Claire Anderson said: “I’m very proud that we have delivered on the commitment to divest from fossil fuels made by the RPS Assembly last year. Our original plan was to be completely disinvested by the end of 2022, and we have achieved this four months ahead of our target date. This is an important milestone for us in our efforts to help tackle the climate and ecological emergency. There’s still plenty to be achieved and we are working hard to become a more sustainable organisation.

“Our Climate Change Charter, in partnership with Pharmacy Declares, helps pharmacy team members to make their commitment to a more sustainable future and I urge you to sign up today. We’ve also prepared a handy list of actions you can take to put your commitment into action. Our annual conference this year will feature sustainability as one of the four main workstreams.”

RPS is a signatory to the Professional Bodies Climate Action Charter and also a member of the UK Health Alliance on Climate Change.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Opioid overdose: Pharmacy professionals to be able to supply naloxone without a prescription

DHSC also publishes a new 10-year strategic plan to expand and improve the drug and alcohol workforce The...

New NHS patient choice scheme offers 5 options, but nursing shortages persist

Royal College of Nursing CE urges caution amidst new NHS patient choice pilot scheme rollout "Patients deserve choice, but...

Prof Ryan Donnelly awarded prestigious RPS Harrison Memorial Medal 2024

RPS HMM winner Professor Donnelly's work has secured £30M+ funding through his pioneering work in developing advanced polymeric...

Pharmacies forced to subsidise NHS medicines: NPA hands £108m invoice to DHSC

The NPA calls for a new deal that reverses “historical funding cuts and gives the sector the respect...